Supplementary Table S2 from Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients

Corrine A. Nief, Phoebe M. Hammer, Aihui Wang, Vivek Charu, Amina Tanweer, Babak Litkouhi, Elizabeth Kidd, Andrew J. Gentles, Brooke E. Howitt
In: American Association for Cancer Research · 2024 · doi:10.1158/1078-0432.26134326 · W4400215140
supplementary-materials OA: gold CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-27 ⓘ

Supplementary Table S2 presents clinical and pathologic variables for endometrioid endometrial carcinoma cases and false negatives of the Endometrioid Endometrial RNA Index in Stanford-EEC and TCGA-UCEC recurrent patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Supplemental Table 2: Clinical and Pathologic Variables of Cases and EERI False Negatives in both the Stanford-EEC cases and TCGA-UCEC recurrent patients

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK